Transcripts
Teva Pharmaceutical Industries Ltd to Discuss New Data Presented for Duvakitug (Anti-TL1A) Phase 2b after ECCO Conference Call Transcript
2025-02-24Conference Presentations
Read the full earnings transcript with Waltermetrics Pro
The complete transcript text is available to Pro members.
Upgrade to Pro